• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Olema Pharmaceuticals, Inc. - Common Stock (NQ:OLMA)

    10.80 -0.05 (-0.46%)
    Streaming Delayed Price Updated: 9:38 AM EDT, Aug 27, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 19,612
    Open 10.70
    Bid (Size) 10.76 (400)
    Ask (Size) 10.85 (200)
    Prev. Close 10.85
    Today's Range 10.62 - 10.82
    52wk Range 5.360 - 36.26
    Shares Outstanding 54,769,800
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Olema Oncology Appoints Jason O’Byrne as Chief Financial Officer
    From Olema Oncology
    Via GlobeNewswire
    News headline image
    Olema Oncology Reports Second Quarter 2026 Financial and Operating Results
    From Olema Oncology
    Via GlobeNewswire

    Performance

    YTD
    -57.3%
    -57.3%
    1 Month
    -10.1%
    -10.1%
    3 Month
    -16.3%
    -16.3%
    6 Month
    -55.2%
    -55.2%
    1 Year
    +88.5%
    +88.5%

    More News

    Read More
    News headline image
    Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Olema Oncology
    Via GlobeNewswire
    News headline image
    Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Olema Oncology
    Via GlobeNewswire
    Olema Pharmaceuticals (NASDAQ:OLMA) Reports Narrower Q1 Loss, Eyes Fall Breast Cancer Data Readout ↗
    Via Chartmill
    Olema Pharmaceuticals Inc (NASDAQ:OLMA) Beats Q4 2025 EPS Estimates, Provides Key Pipeline Updates ↗
    Via Chartmill
    Wondering what's happening in today's after-hours session? ↗
    Via Chartmill
    News headline image
    Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Olema Oncology
    Via GlobeNewswire
    News headline image
    Olema Oncology Announces Clinical Trial Collaboration and Supply Agreement with Bayer to Evaluate OP-3136 in Combination with NUBEQA® (darolutamide) in Metastatic Castration-Resistant Prostate Cancer
    From Olema Oncology
    Via GlobeNewswire
    News headline image
    Olema Oncology Announces Encouraging Initial Clinical Data from the Phase 1 Study of OP-3136, a KAT6 Inhibitor, at 2026 ASCO Annual Meeting
    From Olema Oncology
    Via GlobeNewswire
    News headline image
    Olema Oncology to Participate in Upcoming Investor Conferences
    From Olema Oncology
    Via GlobeNewswire
    News headline image
    Olema Oncology Reports First Quarter 2026 Financial and Operating Results
    From Olema Oncology
    Via GlobeNewswire
    News headline image
    Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Olema Oncology
    Via GlobeNewswire
    News headline image
    Olema Oncology Appoints Prakash Raman, Ph.D., to Board of Directors
    From Olema Oncology
    Via GlobeNewswire
    News headline image
    Olema Oncology to Present Initial Clinical Data for OP-3136 at the 2026 ASCO Annual Meeting
    From Olema Oncology
    Via GlobeNewswire
    News headline image
    Olema Oncology Announces Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting
    From Olema Oncology
    Via GlobeNewswire
    News headline image
    Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Olema Oncology
    Via GlobeNewswire
    News headline image
    Olema Stock Up 242%, but Does a $122 Million Position Suggest More Upside Potential? ↗
    Via The Motley Fool
    News headline image
    Olema Oncology to Present Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting
    From Olema Oncology
    Via GlobeNewswire
    News headline image
    Biotech Stock Up Nearly 300% Draws $68.7 Million Bet as Breast Cancer Drug Targets 2027 Launch ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Olema Oncology Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
    From Olema Oncology
    Via GlobeNewswire
    News headline image
    A Healthcare Hedge Fund Just Added $24.5 Million in Immunovant Stock. Should you? ↗
    Via The Motley Fool
    Top stock movements in today's session. ↗
    Via Chartmill
    News headline image
    Olema Pharmaceuticals, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – OLMA
    From DJS Law Group
    Via Business Wire
    Monday's session: top gainers and losers ↗
    Via Chartmill

    Frequently Asked Questions

    Is Olema Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Olema Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Olema Pharmaceuticals, Inc. - Common Stock trade on?
    Olema Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Olema Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Olema Pharmaceuticals, Inc. - Common Stock is OLMA on the Nasdaq Stock Market
    What is the current price of Olema Pharmaceuticals, Inc. - Common Stock?
    The current price of Olema Pharmaceuticals, Inc. - Common Stock is 10.80
    When was Olema Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Olema Pharmaceuticals, Inc. - Common Stock was at 08/27/26 09:38 AM ET
    What is the market capitalization of Olema Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of Olema Pharmaceuticals, Inc. - Common Stock is 591.51M
    How many shares of Olema Pharmaceuticals, Inc. - Common Stock are outstanding?
    Olema Pharmaceuticals, Inc. - Common Stock has 592M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.